Exact Mass: 604.1689308
Exact Mass Matches: 604.1689308
Found 50 metabolites which its exact mass value is equals to given mass value 604.1689308,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ferrocytochrome
C33H32FeN4O4 (604.1772821999999)
Ferricytochrome is a cytochrome containing reduced (ferrous) iron. Cytochrome c is an electron-carrying protein found in mitochondria of all aerobic organisms. It is part of the terminal oxidation chain, which completes the breakdown of foods to COZ and HzO, storing the liberated chemical energy in molecules of ATP. Like myoglobin, it is an iron porphyrin protein, made up of one heme group and one polypeptide chain. The iron atomalternates between the +2 and +3 oxidation state as the molecule interacts in turn with cytochrome reductase and cytochrome oxidase, each a large multimolecular complex (l-3). One of the goals of the present x-ray analysis is to understand how electron. transfer occurs into and out of cytochrome c, which will ultimately require a knowledge of the molecular structure in both the ferric and ferrous states. Ferricytochrome is a cytochrome containing reduced (ferrous) iron.
Modipafant
N-[4-[[3-[(1-Ethyl-3-fluoropiperidin-4-yl)amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide
Isorhamnetin 3-O-beta-D-2,3,4-triacetylglucopyranoside
kadsuphilol U|rel-(5R,6R,7R,8S,14aR)-5-(acetyloxy)-5,6,7,8-tetrahydro-6-hydroxy-2,3-dimethoxy-6,7-dimethyl-1-oxo-1H,14H-10,12,13-trioxabenzo[1,8]cyclooct[1,2,3-cd]-as-indacen-8-yl (2E)-3-phenylprop-2-enoate
(11S,13R,14R,15R)-11,13,15-trichlorodocosane-1,14-disulfate
C22H43Cl3O8S2 (604.1464808000001)
(1R,2S,4S,5S,6R,7R,9S,10S)-9-benzoyloxy-1,2,6,15-tetra-acetoxy-4-hydroxy-8-oxo-dihydro-beta-agarofuran
kadsuphilol V|rel-(5R,6R,7R,8S,14aR)-5-(acetyloxy)-5,6,7,8-tetrahydro-6-hydroxy-1,2-dimethoxy-6,7-dimethyl-3-oxo-3H,14H-10,12,13-trioxabenzo[1,8]cyclooct[1,2,3-cd]-as-indacen-8-yl (2E)-3-phenylprop-2-enoate
6?-O-p-hydroxybenzoyl-6-O-p-hydroxybenzoyl-5,7-bisdeoxycynanchoside
2-(3-Hydroxy-4-methoxyphenyl)-2-(3,4-dihydroxyphenyl)-3,5,5,7,7-pentahydroxy-2,2,3,3-tetrahydro-3,8-bi(4H-1-benzopyran-4-one)
Dehydrobruceantinol
3-O-[(E)-3,4,5-trimethoxycinnamoyl]-beta-D-fructofuranosyl-(2->1)-(6-O-acetyl)-alpha-D-glucopyranoside|tricornose A
kaempferol 3-O-alpha-L-(4-O-acetyl)rhamnopyranoside-7-O-alpha-L-rhamnopyranoside|sutchuenoside A
1alpha,8alpha-oxido-3beta-acetoxy-2alpha-acelperoxy-1alpha,14alpha-dihydroxy-[3.3.110,2]-bicyclomeliac-7,19-olide
3-hydroxyphloretin 4-(6-O-galloyl-beta-D-glucopyranoside)|3-hydroxyphloretin 4-O-(6-O-galloyl-beta-D-glucopyranoside)|3-hydroxyphloretin 4?-O-[6??-O-galloyl]-beta-D-glucopyranoside
Hp 5B
(-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate
O-Allyl-N-(9-anthracenylmethyl)cinchonidinium bromide
(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate
alpha-D-GlcpA4Me-(1->2)-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-beta-D-Xylp
N-[(5S,6R,9R)-8-(3-chlorophenyl)sulfonyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
C28H33ClN4O7S (604.1758378000001)
1-(2-fluorophenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(2S,3S,4R,5R,6S)-4,5-dihydroxy-6-[(2S,3R,4S,5R)-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-3-yl]oxy-3-methoxyoxane-2-carboxylic acid
8-demethyl-8-(alpha-L-rhamnosyl)tetracenomycin C
A member of the class of tetracenomycins that is 8-demethyltetracenomycin C in which the hydroxyl hydrogen at position 8 is replaced by an alpha-L-rhamnosyl residue.
IPN60090 (dihydrochloride)
IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1?(GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers[1][2].